Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Breast Cancer Research : BCR|June 7, 2011
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4Robert L SutherlandBreast Cancer Research : BCR|March 7, 2002
Cyclin D1 and mammary carcinoma: new insights from transgenic mouse modelsRobert L Sutherland, Elizabeth A MusgroveJournal of Mammary Gland Biology and Neoplasia|April 15, 2004
Cyclins and breast cancerRobert L Sutherland, Elizabeth A MusgroveBreast Cancer Research : BCR|January 14, 2010
CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ diseaseRobert L Sutherland, Elizabeth A MusgroveNature Reviews. Cancer|August 25, 2009
Biological determinants of endocrine resistance in breast cancerElizabeth A Musgrove, Robert L SutherlandCritical Reviews in Oncogenesis|April 5, 2012
Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeuticsAndrew Stone, Robert L Sutherland, Elizabeth A MusgroveCell Cycle (Georgetown, Tex.)|May 18, 2010
Cell cycle proteins in epithelial cell differentiation: implications for breast cancerC Elizabeth Caldon, Robert L Sutherland, Elizabeth MusgroveExpert Opinion on Therapeutic Targets|August 8, 2009
The Hedgehog signalling pathway as a therapeutic target in early breast cancer developmentSandra A O'Toole, Alexander Swarbrick, Robert L SutherlandEuropean Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Molecular markers of prostate cancer outcomeDavid I Quinn, Susan M Henshall, Robert L SutherlandBreast Cancer Research : BCR|November 6, 2007
Live or let die: oestrogen regulation of survival signalling in endocrine responseAlison J Butt, Robert L Sutherland, Elizabeth A MusgrovePageof 16